Skip to content

Higher and standard vitamin D groups showed no significant difference in testosterone changes

Among women with early-stage breast cancer, testosterone changes did not differ significantly between higher and standard vitamin D targets during follow-up.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Testosterone changes did not differ significantly between the higher and standard vitamin D groups during follow-up. The analysis concerns a blood hormone measurement in breast cancer survivors. It does not prove the approaches equivalent, establish overall safety, or show how testosterone would change without supplementation, since both groups received vitamin D.

Keep in mind

The analysis was limited to women with complete measurements. The abstract gives no confidence interval for the between-group difference, which limits assessment of precision, and neither group served as an unsupplemented comparison.

THE NUMBERS, WITH CONTEXT

What researchers found

p = 0.682

Between-group comparison of serum testosterone changes

Higher versus standard vitamin D targets over 24 months; no statistically significant difference was detected.

Int J Mol Sci, 2025 · Original source ↓

What changed during follow-up

Researchers tracked blood testosterone from baseline through follow-up. Vitamin D levels rose significantly in both groups during supplementation, while the comparison of testosterone changes between the groups was not statistically significant.

A predictor, with an uncertain explanation

Starting testosterone was the most statistically significant predictor of later testosterone patterns. The authors suggested that hormone-suppressive therapy might influence those patterns; the abstract does not establish that explanation or quantify the predictor's effect size.

CHECK THE ORIGINAL

The original publication

Vitamin D Supplementation and Testosterone Levels in Breast Cancer Survivors.

Minopoli A, Di Gennaro P, Porciello G et al.
Int J Mol Sci · 2025

PubMed ID
41155322
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.